{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+1%3A+SAD+placebo&page=2", "query": { "intervention": "Part 1: SAD placebo", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 124, "total_pages": 13, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+1%3A+SAD+placebo&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+1%3A+SAD+placebo&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-05T12:01:52.332Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06247345", "title": "A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alzheimer Disease" ], "interventions": [ { "name": "ADEL-Y01 - healty participants", "type": "DRUG" }, { "name": "Placebo - Healthy Participants", "type": "DRUG" }, { "name": "ADEL-Y01 - MCI/AD", "type": "DRUG" }, { "name": "Placebo - MCI/AD", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alzheimer's Disease Expert Lab (ADEL), Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 42, "start_date": "2024-02-06", "completion_date": "2026-01-07", "has_results": false, "last_update_posted_date": "2026-04-30", "last_synced_at": "2026-10-05T12:01:52.332Z", "location_count": 6, "location_summary": "Anaheim, California • Lady Lake, Florida • Maitland, Florida + 3 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Lady Lake", "state": "Florida" }, { "city": "Maitland", "state": "Florida" }, { "city": "Palmetto Bay", "state": "Florida" }, { "city": "Decatur", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06247345" }, { "nct_id": "NCT07223216", "title": "Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "BMF-650", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biomea Fusion Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 80, "start_date": "2025-10-23", "completion_date": "2026-06", "has_results": false, "last_update_posted_date": "2026-04-09", "last_synced_at": "2026-10-05T12:01:52.332Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07223216" }, { "nct_id": "NCT06690996", "title": "A Study of LY4005130 in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "LY4005130", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 110, "start_date": "2024-11-08", "completion_date": "2026-04-28", "has_results": false, "last_update_posted_date": "2026-06-23", "last_synced_at": "2026-10-05T12:01:52.332Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06690996" }, { "nct_id": "NCT03516487", "title": "Safety and Tolerability of SYNB1618 in Healthy Adult Volunteers and Adult Subjects With Phenylketonuria", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Phenylketonuria", "Healthy" ], "interventions": [ { "name": "SYNB1618", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Synlogic", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 70, "start_date": "2018-04-17", "completion_date": "2019-06-21", "has_results": false, "last_update_posted_date": "2021-05-13", "last_synced_at": "2026-10-05T12:01:52.332Z", "location_count": 4, "location_summary": "Boston, Massachusetts • Pittsburgh, Pennsylvania • Nashville, Tennessee + 1 more", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT03516487" }, { "nct_id": "NCT05979428", "title": "A Study to Look at How Safe a New Medicine (NNC0491-6075) is in Healthy People and in Participants With High Levels of Fat in the Blood", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers", "Dyslipidaemia" ], "interventions": [ { "name": "NNC0491-6075", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 106, "start_date": "2023-08-07", "completion_date": "2025-03-14", "has_results": false, "last_update_posted_date": "2026-09-01", "last_synced_at": "2026-10-05T12:01:52.332Z", "location_count": 1, "location_summary": "Cypress, California", "locations": [ { "city": "Cypress", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05979428" }, { "nct_id": "NCT07590193", "title": "A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "AMG 127", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 162, "start_date": "2026-06-11", "completion_date": "2027-10-02", "has_results": false, "last_update_posted_date": "2026-08-03", "last_synced_at": "2026-10-05T12:01:52.332Z", "location_count": 2, "location_summary": "Lake Forest, California • Aventura, Florida", "locations": [ { "city": "Lake Forest", "state": "California" }, { "city": "Aventura", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07590193" }, { "nct_id": "NCT06637371", "title": "A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "AMG 691", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 21, "start_date": "2024-10-16", "completion_date": "2027-04-10", "has_results": false, "last_update_posted_date": "2026-06-17", "last_synced_at": "2026-10-05T12:01:52.332Z", "location_count": 15, "location_summary": "Lake Forest, California • Aventura, Florida • Palmetto Bay, Florida + 12 more", "locations": [ { "city": "Lake Forest", "state": "California" }, { "city": "Aventura", "state": "Florida" }, { "city": "Palmetto Bay", "state": "Florida" }, { "city": "Columbus", "state": "Georgia" }, { "city": "White Marsh", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06637371" }, { "nct_id": "NCT06122714", "title": "A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 Following Single and Multiple Ascending Doses Via Oral Administration to Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants" ], "interventions": [ { "name": "AZD4144 Part A", "type": "DRUG" }, { "name": "AZD4144 Part B", "type": "DRUG" }, { "name": "Placebo Part A", "type": "DRUG" }, { "name": "Placebo Part B", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 95, "start_date": "2023-11-07", "completion_date": "2024-12-04", "has_results": false, "last_update_posted_date": "2024-12-13", "last_synced_at": "2026-10-05T12:01:52.332Z", "location_count": 2, "location_summary": "Glendale, California • Brooklyn, Maryland", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Brooklyn", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06122714" }, { "nct_id": "NCT03251092", "title": "Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Healthy Volunteer - Complete", "Cystic Fibrosis - Complete" ], "interventions": [ { "name": "PTI-808", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "PTI-428", "type": "DRUG" }, { "name": "PTI-801", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Proteostasis Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 179, "start_date": "2017-07-17", "completion_date": "2019-12-23", "has_results": false, "last_update_posted_date": "2020-04-22", "last_synced_at": "2026-10-05T12:01:52.332Z", "location_count": 22, "location_summary": "Tucson, Arizona • Stanford, California • Denver, Colorado + 18 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Stanford", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Altamonte Springs", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03251092" }, { "nct_id": "NCT07116889", "title": "A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma", "COPD (Chronic Obstructive Pulmonary Disease)" ], "interventions": [ { "name": "GB-0895 (SC)", "type": "BIOLOGICAL" }, { "name": "Placebo (SC)", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Generate Biomedicines", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 156, "start_date": "2023-12-12", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2025-11-05", "last_synced_at": "2026-10-05T12:01:52.332Z", "location_count": 6, "location_summary": "DeLand, Florida • Miami, Florida • Orlando, Florida + 3 more", "locations": [ { "city": "DeLand", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Saint Paul", "state": "Minnesota" }, { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT07116889" } ] }